Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Nov;94(5):512-520.
doi: 10.1016/j.contraception.2016.05.012. Epub 2016 May 31.

Assessment of the vaginal residence time of biomarkers of semen exposure

Andrea Thurman  1 , Terry Jacot  2 , Johan Melendez  2 , Thomas Kimble  2 , Margaret Snead  2 , Roxanne Jamshidi  2 , Angie Wheeless  2 , David F Archer  2 , Gustavo F Doncel  2 , Christine Mauck  2
Affiliations
Randomized Controlled Trial

Assessment of the vaginal residence time of biomarkers of semen exposure

Andrea Thurman et al. Contraception. 2016 Nov.

Abstract

Objective: The primary objective of this pilot study is to determine and compare the residence time in the vagina of biomarkers of semen exposure for up to 15 days post exposure. The biomarkers are prostate-specific antigen (PSA), Y chromosome DNA, the sex determining region of the Y chromosome (SRY) and testis-specific protein Y-encoded 4 (TSPY4). The secondary objectives are to determine if biomarker concentrations differed between intercourse and inoculation groups, to establish whether the sampling frequency post exposure affected biomarker concentrations and decay profile and to determine if biomarker concentrations in vaginal swabs obtained by the participant at home were similar to swabs obtained by the nurse in the clinic.

Study design: We randomized healthy women to unprotected intercourse (n=17) versus vaginal inoculation with the male partner's semen in the clinic (n=16). Women were then further randomized to have vaginal swabs obtained at either 7 or 4 time points after semen exposure, up to 15 days post exposure, either obtained at home by the participant or in the clinic by the research nurse.

Results: PSA and SRY were markers of recent semen exposure. TSPY4 was detectable in approximately 50% of participants at 15 days post exposure. Unprotected intercourse resulted in significantly higher concentrations of select biomarkers. Sampling frequency and home versus clinic sampling had no significant effect on biomarker concentrations.

Conclusions: Objective biomarkers of recent or distant semen exposure may have great utility for verifying protocol compliance in a variety of clinical trials.

Trial registration: ClinicalTrials.gov NCT00984555.

Keywords: Biomarker; Clinical trials; Semen; Y chromosome.

PubMed Disclaimer

Conflict of interest statement

☆☆ No authors report any conflicts of interest.

Figures

Fig. 1
Fig. 1
(a) Decay Curves for Semen Biomakers, Based on Vaginal Inoculation (Groups A1 and A2) versus Intercourse (Groups B1 and B2) YcDNA (SRY by qPCR). (b) Decay Curves for Semen Biomakers, Based on Vaginal Inoculation (Groups A1 and A2) versus Intercourse (Groups B1 and B2) SRY by Multiplex PCR. (c) Decay Curves for Semen Biomakers, Based on Vaginal Inoculation (Groups A1 and A2) versus Intercourse (Groups B1 and B2) TSPY4 by Multiplex PCR. (d) Decay Curves for Semen Biomakers, Based on Vaginal Inoculation (Groups A1 and A2) versus Intercourse (Groups B1 and B2) TSPY4 by Multiplex PCR. (e) Decay Curves for Semen Biomarkers, Based on Vaginal Inoculation (Groups A1 and A2) versus Intercourse (Groups B1 and B2) TSPY4 by qPCR (Mean Values, ng/mL), Main Study, Treated Population.
Fig. 1
Fig. 1
(a) Decay Curves for Semen Biomakers, Based on Vaginal Inoculation (Groups A1 and A2) versus Intercourse (Groups B1 and B2) YcDNA (SRY by qPCR). (b) Decay Curves for Semen Biomakers, Based on Vaginal Inoculation (Groups A1 and A2) versus Intercourse (Groups B1 and B2) SRY by Multiplex PCR. (c) Decay Curves for Semen Biomakers, Based on Vaginal Inoculation (Groups A1 and A2) versus Intercourse (Groups B1 and B2) TSPY4 by Multiplex PCR. (d) Decay Curves for Semen Biomakers, Based on Vaginal Inoculation (Groups A1 and A2) versus Intercourse (Groups B1 and B2) TSPY4 by Multiplex PCR. (e) Decay Curves for Semen Biomarkers, Based on Vaginal Inoculation (Groups A1 and A2) versus Intercourse (Groups B1 and B2) TSPY4 by qPCR (Mean Values, ng/mL), Main Study, Treated Population.
Fig. 1
Fig. 1
(a) Decay Curves for Semen Biomakers, Based on Vaginal Inoculation (Groups A1 and A2) versus Intercourse (Groups B1 and B2) YcDNA (SRY by qPCR). (b) Decay Curves for Semen Biomakers, Based on Vaginal Inoculation (Groups A1 and A2) versus Intercourse (Groups B1 and B2) SRY by Multiplex PCR. (c) Decay Curves for Semen Biomakers, Based on Vaginal Inoculation (Groups A1 and A2) versus Intercourse (Groups B1 and B2) TSPY4 by Multiplex PCR. (d) Decay Curves for Semen Biomakers, Based on Vaginal Inoculation (Groups A1 and A2) versus Intercourse (Groups B1 and B2) TSPY4 by Multiplex PCR. (e) Decay Curves for Semen Biomarkers, Based on Vaginal Inoculation (Groups A1 and A2) versus Intercourse (Groups B1 and B2) TSPY4 by qPCR (Mean Values, ng/mL), Main Study, Treated Population.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Graves HC, Sensabaugh GF, Blake ET. Postcoital detection of a male-specific semen protein. Application to the investigation of rape. N Engl J Med. 1985;312:338–43. - PubMed
    1. Mauck CK, Weaver MA, Schwartz JL, Walsh T, Joanis C. Critical next steps for female condom research–report from a workshop. Contraception. 2009;79:339–44. - PubMed
    1. Mauck CK. Biomarkers of semen exposure. Sex Transm Dis. 2009;36:S81–3. - PubMed
    1. Mauck CK, Straten A. Using objective markers to assess participant behavior in HIV prevention trials of vaginal microbicides. J Acquir Immune Defic Syndr. 2008;49:64–9. - PubMed
    1. Ghanem KG, Melendez JH, McNeil-Solis C, Giles JA, Yuenger J, Smith TD, et al. Condom use and vaginal Y-chromosome detection: the specificity of a potential biomarker. Sex Transm Dis. 2007;34:620–3. - PubMed

Publication types

Associated data